However, the definitive diagnosis of TSC relies on molecular genetic testing to identify a heterozygous pathogenic variant in a TSC-associated gene (TSC1 or TSC2), regardless of clinical findings (5, 6). Here, TSC2 is linked to tuberous sclerosis.